Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Immune Design Corp. (IMDZ) Create: Alert

All | News | Filings
Date FiledTypeDescription
11/06/2018 8-K Quarterly results
Docs: "Immune Design Reports Third Quarter 2018 Financial Results and Provides Corporate Update – Conference call at 1:30 pm Pacific today"
05/02/2018 8-K Quarterly results
Docs: "Immune Design Reports First Quarter 2018 Financial Results and Provides Corporate Update • The higher dose of CMB305 was deemed safe and cleared for the pivotal Phase 3 • The 20ug dose of G100 shows a two-fold increase in TILs, higher than that seen at the 10ug dose • Conference call at 1:30 pm Pacific today"
03/14/2018 8-K Quarterly results
Docs: "Immune Design Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update – New positive clinical and translational data for both lead agents – Strong balance sheet with 2017 year-end cash and equivalents of $144.2 Million – Conference call at 1:30 pm Pacific today"
11/01/2017 8-K Quarterly results
Docs: "Immune Design Reports Third Quarter 2017 Financial Results and Provides Corporate Update Company conference call at 1:30 p.m. PT today"
08/02/2017 8-K Quarterly results
Docs: "Immune Design Reports Second Quarter 2017 Financial Results and Provides Corporate Update Company conference call at 1:30 p.m. PT today"
05/17/2017 8-K Form 8-K - Current report
03/07/2017 8-K Form 8-K - Current report
11/09/2016 8-K Form 8-K - Current report
08/09/2016 8-K Quarterly results
Docs: "Immune Design Reports Second Quarter 2016 Financial Results and Provides Corporate Update Company conference call at 1:30 p.m. PT today"
05/10/2016 8-K Form 8-K - Current report
03/10/2016 8-K Form 8-K - Current report
11/12/2015 8-K Quarterly results
Docs: "Immune Design Reports Third Quarter 2015 Financial Results Company to hold conference call at 1:30 pm Pacific today"
08/12/2015 8-K Quarterly results
Docs: "Immune Design Reports Second Quarter 2015 Financial Results Company to hold conference call at 1:30 pm Pacific today"
05/14/2015 8-K Quarterly results
Docs: "Immune Design Reports First Quarter 2015 Financial Results",
"Immune Design Announces Positive Data from Three Phase 1studies at the 2015 American Society of Clinical Oncology Annual Meeting"
03/31/2015 8-K Quarterly results
Docs: "Immune Design Reports Fourth Quarter and Full Year 2014 Financial Results and Provides Corporate Update",
"Immune Design Announces Positive Topline Data from Three Phase 1 Clinical Trials of Immuno-Oncology Agents"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy